We did recently announce trials with a number of London and Cambridge based hospitals. Resource usage and costs will be measured together with diagnosis accuracy compared with a hospital clinician.
As previously mentioned I would expect the trials to be on hold, however what better time than the COVID crisis to evaluate?
https://www.resapphealth.com.au/wp-content/uploads/2020/03/2046712.pdf
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp to Present at TechKnow Invest Roadshow Webinar
Ann: ResApp to Present at TechKnow Invest Roadshow Webinar, page-24
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)